|
IT1115596B
(it)
*
|
1978-03-13 |
1986-02-03 |
Bayer Italia Spa |
Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
|
|
FR2471186A1
(fr)
*
|
1979-12-10 |
1981-06-19 |
Roussel Uclaf |
Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
|
|
WO1981002671A1
(en)
*
|
1980-03-20 |
1981-10-01 |
Ferring Farma Lab |
Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
|
|
US4960765A
(en)
*
|
1980-03-20 |
1990-10-02 |
Farmaceutisk Laboratorium Ferring A/S |
Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
|
|
SE8003805L
(sv)
*
|
1980-05-21 |
1981-11-22 |
Haessle Ab |
En farmaceutisk beredning med forbettrade utlosningsegenskap
|
|
ZA825384B
(en)
*
|
1981-07-31 |
1983-05-25 |
Tillott J B Ltd |
Orally administrable pharmaceutical compositions
|
|
FR2532177A1
(fr)
*
|
1982-08-30 |
1984-03-02 |
Being Well Products Inc |
Complement nutritionnel a zones de liberation determinees et son procede de fabrication
|
|
SE457505B
(sv)
*
|
1984-01-10 |
1989-01-09 |
Lejus Medical Ab |
Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
|
|
DK62184D0
(da)
*
|
1984-02-10 |
1984-02-10 |
Benzon As Alfred |
Diffusionsovertrukket polydepotpraeparat
|
|
IE59287B1
(en)
*
|
1984-02-10 |
1994-02-09 |
Benzon Pharma As |
Diffusion coated multiple-units dosage form
|
|
US4668517A
(en)
*
|
1985-04-04 |
1987-05-26 |
Norwich Eaton Pharmaceuticals, Inc. |
Furazolidone dosage form
|
|
US4775536A
(en)
*
|
1986-02-24 |
1988-10-04 |
Bristol-Myers Company |
Enteric coated tablet and process for making
|
|
GB2189698A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated omeprazole tablets
|
|
US4857337A
(en)
*
|
1988-05-24 |
1989-08-15 |
American Home Products Corp. (Del) |
Enteric coated aspirin tablets
|
|
IT1230576B
(it)
*
|
1988-10-20 |
1991-10-28 |
Angeli Inst Spa |
Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
|
|
US4965089A
(en)
*
|
1989-04-10 |
1990-10-23 |
Sauter Manufacturing Corp. |
Method and apparatus for the gelatin coating of caplets
|
|
US5316772A
(en)
*
|
1990-12-19 |
1994-05-31 |
Solvay & Cie, S.A. (Societe Anonyme) |
Bilayered oral pharmaceutical composition with pH dependent release
|
|
US5843479A
(en)
*
|
1993-02-26 |
1998-12-01 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
|
US5651983A
(en)
*
|
1993-02-26 |
1997-07-29 |
The Procter & Gamble Company |
Bisacodyl dosage form for colonic delivery
|
|
US5914132A
(en)
*
|
1993-02-26 |
1999-06-22 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
AU689250B2
(en)
|
1994-04-22 |
1998-03-26 |
Astellas Pharma Inc. |
Colon-specific drug release system
|
|
US5637319A
(en)
*
|
1995-03-01 |
1997-06-10 |
Takada; Kanji |
Controlled-release preparations
|
|
US5686106A
(en)
*
|
1995-05-17 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form for colonic delivery
|
|
US6623759B2
(en)
|
1996-06-28 |
2003-09-23 |
Astrazeneca Ab |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
|
|
US20060116330A1
(en)
*
|
1997-07-08 |
2006-06-01 |
The Iams Company |
Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
|
|
US8563522B2
(en)
*
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
|
US20020035071A1
(en)
*
|
1997-07-08 |
2002-03-21 |
Josef Pitha |
Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
|
|
US6296876B1
(en)
|
1997-10-06 |
2001-10-02 |
Isa Odidi |
Pharmaceutical formulations for acid labile substances
|
|
US8168170B2
(en)
*
|
2002-10-03 |
2012-05-01 |
The Procter And Gamble Company |
Compositions having an inner core and at least three surrounding layers
|
|
US8802139B2
(en)
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
|
RU2375048C2
(ru)
*
|
2003-07-17 |
2009-12-10 |
Д-Р Редди'С Лабораторис Инк. |
Фармацевтическая композиция с набухающим покрытием
|
|
US8894991B2
(en)
*
|
2003-12-19 |
2014-11-25 |
The Iams Company |
Canine probiotic Lactobacilli
|
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
|
US20050158294A1
(en)
*
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
US7785635B1
(en)
|
2003-12-19 |
2010-08-31 |
The Procter & Gamble Company |
Methods of use of probiotic lactobacilli for companion animals
|
|
US20050152884A1
(en)
*
|
2003-12-19 |
2005-07-14 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria globosum
|
|
US7670624B2
(en)
*
|
2004-01-29 |
2010-03-02 |
Astella Pharma Inc. |
Gastrointestinal-specific multiple drug release system
|
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
|
CA2609617C
(en)
*
|
2005-05-31 |
2014-07-08 |
The Iams Company |
Feline probiotic lactobacilli
|
|
AR053805A1
(es)
*
|
2005-05-31 |
2007-05-23 |
Iams Company |
Bifidobacterias probioticas para felinos
|
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
|
RU2309731C1
(ru)
*
|
2006-09-29 |
2007-11-10 |
Исаак Григорьевич Гитлин |
Гранулят эметина гидрохлорида, способ его получения и лекарственная форма на его основе
|
|
MX2009008166A
(es)
|
2007-02-01 |
2009-08-12 |
Iams Company |
Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
|
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
|
CA2885680C
(en)
|
2011-09-07 |
2022-10-04 |
Roland Saur-Brosch |
Formulation for the controlled release of one or several substances in the digestive tract of a mammal.
|
|
US10653631B2
(en)
|
2011-09-07 |
2020-05-19 |
Roland SAUR-BROSCH |
Optimal colon targeting technology
|